ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,494.70
0.26%
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs Yen
155.408
0.42%
Brent Oil
82.26
-0.73%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/0819 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HTHTH World Group Ltd
2024/05/0819 : 30Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLLL Flooring Holdings Inc
2024/05/0819 : 30GlobeNewswire Inc.Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorderTG:5Y6Compass Pathways Plc
2024/05/0819 : 30GlobeNewswire Inc.Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical ProgramNASDAQ:VERUVeru Inc
2024/05/0819 : 30GlobeNewswire Inc.Kraken Robotics Receives $3.5 Million of Orders for Subsea Security EquipmentTSXV:PNGKraken Robotics Inc
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaNYSE:TEVATeva Pharmaceutical Industries Ltd
2024/05/0819 : 30GlobeNewswire Inc.Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
2024/05/0819 : 30Business WireHF Sinclair Corporation Reports 2024 First Quarter Results and Announces Regular Cash DividendNYSE:DINOHF Sinclair Corporation
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaEU:MEDCLMedincell SA
2024/05/0819 : 30Business WireEaton to supply innovative ELocker differential system to leading electrified vehicle manufacturer
2024/05/0819 : 30GlobeNewswire Inc.Ducommun Incorporated Reports First Quarter 2024 ResultsNYSE:DCODucommun Inc
2024/05/0819 : 30Business WireAult Alliance’s Subsidiary, Sentinum, Completes Initial Bitcoin Mining Installation at Montana LocationAMEX:AULTAult Alliance Inc
2024/05/0819 : 30Business WireLubrizol Showcases LIPOFER™ Microencapsulation Technology, Introduces New EU Food-Grade Approval for Carbopol® Polymers at Vitafoods Europe 2024
2024/05/0819 : 30GlobeNewswire Inc.Azimut and SOQUEM Cut Very High Grade Lithium Drill Intercepts on Galinée, James Bay Region, QuebecTSXV:AZMAzimut Exploration Inc
2024/05/0819 : 30Business WireTeva et Medincell annoncent des résultats d'efficacité positifs pour l’essai de phase 3 SOLARIS de TEV-‘749 (olanzapine / mdc-TJK), injection sous-cutanée à action prolongée mensuelle pour les adultes atteints de schizophrénieEU:MEDCLMedincell SA
2024/05/0819 : 30Business WireWolverine Worldwide Appoints Taryn Miller as Chief Financial OfficerNYSE:WWWWolverine World Wide Inc
2024/05/0819 : 30Business WireTrane Technologies and the U.S. Department of Energy Partner to Advance Building Decarbonization in New Heat Pump Technology ChallengeNYSE:TTTrane Technologies plc
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaEU:MEDCLMedincell SA
2024/05/0819 : 30Business WireAmerican Clinical Research Services Announces Strategic Acquisition of Elixia
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaEU:MEDCLMedincell SA
2024/05/0819 : 30GlobeNewswire Inc.Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorderNASDAQ:CMPSCOMPASS Pathways PLC
2024/05/0819 : 30Business WireITT Announces Participation at 17th Annual Wolfe Research Global Transportation & Industrials Conference on May 22NYSE:ITTITT Inc
2024/05/0819 : 30Business WireNiSource Announces First Quarter 2024 ResultsNYSE:NINisource Inc
2024/05/0819 : 30PR Newswire (US)LION ELECTRIC ANNOUNCES FIRST QUARTER 2024 RESULTSNYSE:LEVLion Electric Company
2024/05/0819 : 30PR Newswire (US)Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IMUXImmunic Inc
2024/05/0819 : 30PR Newswire (US)UAV (Drone) Market worth $48.5 billion by 2029 - Exclusive Report by MarketsandMarkets™
2024/05/0819 : 30PR Newswire (US)Kennametal Announces Fiscal 2024 Third Quarter ResultsNYSE:KMTKennametal Inc
2024/05/0819 : 30PR Newswire (Canada)CGI et Nokia permettront aux entreprises d'accroître leur agilité organisationnelle grâce à des réseaux privés 5GNYSE:GIBCGI Inc
2024/05/0819 : 30PR Newswire (Canada)LION ELECTRIC ANNOUNCES FIRST QUARTER 2024 RESULTSNYSE:LEVLion Electric Company
2024/05/0819 : 30PR Newswire (US)United Parks & Resorts Inc. Reports First Quarter 2024 ResultsNYSE:PRKSUnited Parks & Resorts Inc

最近閲覧した銘柄

NYSE
BAC
Bank of America
FX
USDEUR
US Dollar vs Euro
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
USI
USTECH100
US Tech 100
FX
USDJPY
US Dollar vs Yen
NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有